baber/WOPTO huggingface dataset:
Patent CA-2622065-A1 (CA)
Inventor: MCRAE SHELLEY
IPC: B44D3/18
Filed: 2008-02-21
Abstract: An easel attachment, for holding a canvas assembly having a peripheral frame defining an inside edge and with a canvas mounted on one side of said peripheral frame and a central opening on the other side, comprises a support member and a plurality of canvas assembly fasteners mounted on said support member. At least one of the canvas assembly fasteners is slidably connected to the support member and said slidable canvas assembly fastener is adjustably located along at least part of the length of said support member and securable at a set location along said adjustable length so as to enable engagement of the canvas assembly fasteners to said inside edge of the canvas assembly's peripheral frame through the central opening. Other embodiments, including easel embodiments, and methods aspects are also provided.
Patent CA-2622638-A1 (CA)
Title: Systeme et procede de mappage tridimensionnel d'informations d'electrophysiologie
Inventor: SCHWEITZER JEFFREY A
IPC: A61B5/04
Filed: 2006-09-12
Abstract: L'invention concerne un appareil d'électrophysiologie (8) utilisé pour mesurer une activité électrique se produisant dans le coeur (10) d'un patient (11) et visualiser ladite activité électrique et/ou les informations relatives à cette activité électrique. On crée une carte dimensionnelle de l'activité électrique et/ou des informations relatives à l'activité électrique. On affecte des couleurs, des nuances de couleur et/ou des échelles de gris à des valeurs de paramètre, et des couleurs correspondant aux paramètres des électrogrammes échantillonnés par des électrodes (par exemple, 12, 14, 16, 17, 18, 19, 22) sont mises à jour sur le modèle tridimensionnel (62).
Patent CA-2623114-A1 (CA)
Title: Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
Inventor: MAELICKE ALFRED
IPC: C07D307/00
Filed: 2006-09-22
Abstract: The present invention refers to compounds that, in addition to enhancing the sensitivity to acetylcholine and choline, and their exogenous agonists, of neuronal cholinergic receptors and/or acting as cholinesterase inhibitors and/or neuroprotective agents, have enhanced blood-brain barrier permeability in comparison to their parent compounds. The compounds are derived (either formally by their chemical structure or directly by chemical synthesis) from natural compounds belonging to the class of amaryllidaceae alkaloids e.g.  galanthamine, narwedine and lycoramine, or from metabolites of said compounds.  The compounds of the present invention can either interact as such with their target molecules, or they can act as "pro-drugs", in the sense that after reaching their target regions in the body they are converted by hydrolysis or enzymatic attack to the original parent compound and react as such with their target molecules, or both. Compounds of this invention may be used as medicaments.
Patent CA-2623217-A1 (CA)
Inventor: KEMPEN TONY MATHILDE JOZEF
IPC: A01N43/36
Filed: 2007-01-31
Abstract: The present invention relates to combinations of 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, and copper or zinc compounds which provide an improved protecting effect against fouling organisms. More particularly, the present invention relates to compositions comprising a combination of 4-bromo-2-(4-chlorophenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, together with one or more copper or zinc compounds selected from Cu2O, Cu(OH)2, CuSO4, copper pyrithione, CuSCN, CuCO3, ZnO, ZnCl2, ZnSO4, zineb, and zinc pyrithione; in respective proportions to provide a synergistic effect against fouling organisms and the use of these compositions for protecting materials against fouling organisms.  This invention thus relates to the field of protection of materials, such as underwater objects, protection of wood, wood products, biodegradable materials and coatings.
Patent CA-2626490-A1 (CA)
Inventor: BAHN SABINE
IPC: G01R33/465
Filed: 2006-10-18
Abstract: The invention relates to methods of diagnosing or monitoring a psychotic disorder in a subject comprising providing a test biological sample from the subject, performing spectral analysis on said test biological sample to provide one or more spectra, and, comparing the one or more spectra with one or more control spectra. The invention also relates to methods for diagnosing or monitoring psychotic disorders such as schizophrenic or bipolar disorders, comprising measuring the level of one or more biomarkers present in a biological sample taken from a test subject, said biomarkers being selected from the group consisting of transthyretin, ApoA1 ,: VLDL, LDL and aromatic species such as plasma proteins. The invention also relates to sensors, biosensors, multi-analyte panels, arrays, assays and kits for performing methods of the invention.
Patent CA-2626914-A1 (CA)
Title: Structure d'un batiment destine a heberger des donnees informatiques
Inventor: SERINET GILLES
IPC: F24F3/044
Filed: 2008-03-31
Abstract: La présente invention concerne une structure d'un bâtiment (1) destiné à héberger des données informatiques, comprenant au moins une salle informatique (2) logeant des moyens de traitement informatique, au moins un local technique (5) comprenant des éléments techniques nécessaires au fonctionnement de la salle informatique (2), et au moins un couloir technique (3), caractérisée en ce que la salle informatique (2) est située en périphérie du bâtiment (1), et en ce que le local technique (5) est situé au coeur dudit bâtiment (1).
Patent CA-2627129-A1 (CA)
Title: Methods of using saha and bortezomib for treating cancer
Inventor: FRANKEL STANLEY
IPC: A01N37/18
Filed: 2006-11-03
Abstract: The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor such as suberoylanilide hydroxamic acid (SAHA), or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of one or more anti-cancer agents, including Bortezomib. The HDAC  inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC  inhibitor and the anti-cancer agent may be additive or synergistic.
Patent CA-2627315-A1 (CA)
Title: Ovulation cycle monitoring and management
Inventor: GILMOUR ROBERT
IPC: G01N33/558
Filed: 2006-10-24
Abstract: Methods of monitoring the ovulation cycle of an animal by detecting specific analytes in body fluids, computer program products, devices, data processing systems, and kits for monitoring the ovulation cycle and determining the fertility of female mammals.
Patent CA-2627699-A1 (CA)
Title: Range of motion device
Inventor: RUHOLL KEVIN R
IPC: A61F5/00
Filed: 2006-10-27
Abstract: The present invention provides an orthosis for stretching tissue around a joint of a patient between first and second relatively pivotable body portions. The orthosis includes a first member affixable to the first body portion and including a first extension member extending therefrom. A second member affixable to the second body portion is also included and has a second extension member having an arcuate shape extending therefrom. The second extension member is operatively connected to the first extension member and travels through the first extension member along an arcuate path when the second arm member is moved from a first position to a second position relative to the first arm member.
Patent CA-2632540-A1 (CA)
Title: Lyophilized compositions of a triazolopyrimidine compound
Inventor: KU MANNCHING SHERRY
IPC: A61K35/00
Filed: 2006-12-15
Abstract: The present invention relates to lyophilized compositions of a triazolopyrimidine compound, or a hydrate thereof, or a pharmaceutically acceptable salt of Compound I or hydrate thereof; solutions useful in preparing said lyophilized compositions; methods for preparing such compositions; methods of reconstituting the same; kits containing such compositions; and uses of the compositions for the treatment of cancer.
Patent CA-2632650-A1 (CA)
Inventor: DELATTE YVES
IPC: C03C27/10
Filed: 2006-12-06
Abstract: La présente invention concerne un vitrage comprenant une feuille de verre (4), un film (3) en matériau amortissant, une feuille rigide (5), l'ensemble étant feuilleté, et comprenant un ou plusieurs excitateurs fixés au vitrage.
Patent CA-2640302-A1 (CA)
Title: Method for repairing the surface of a formwork panel
Inventor: DINGLER GERHARD
IPC: B29C73/26
Filed: 2007-02-09
Abstract: The invention relates to a method of repairing the surface of a formwork panel (1) made of plastic. The invention provides for a surface coating of the formwork panel (1) to be removed by machining, for example by a milling cutter (7), and for the formwork panel (1) to then be recoated with the same thickness as the removed surface coating. For the repair, the formwork panel (1) can remain in its frame (6).
Patent CA-2641162-A1 (CA)
Title: System and method for subscription-based advertising
Inventor: KLEIN DAVE
IPC: G06Q30/02
Filed: 2008-10-16
Abstract: The invention comprises a method of providing reward-compensated advertising, comprising: a) registering one or more advertisers with a service provider; b) registering one or more users with the service provider; c) selecting individual users to view content from individual advertisers based on the reward level set by the individual user; and d) compensating the individual user for viewing the advertising content based on the reward level set by the advertiser.
Patent CA-2641878-A1 (CA)
Title: Optical modulator
Inventor: BRUNSON KEVIN MICHAEL
IPC: G02B5/28
Filed: 2007-02-06
Abstract: A micro-opto-electro-mechanical systems (MOEMS) electro optical modulator (2) having an electrically tuneable optical resonator comprising an asymmetric Fabry-Perot etalon incorporating a mirror (10) resiliency biased with respect to a substrate (13) and moveable in relation thereto in response to a voltage applied there-between. The optical modulator (2) is capable of modulating electromagnetic radiation having a plurality of wavelengths. The modulator is adapted to modulate the transmission of short wave infrared radiation (SWIR), medium wave infrared radiation (MWIR) and long wave infrared radiation (LWIR) and the reflection of visible radiation. A spatial optical modulator having a plurality of said MOEMS optical modulators (2). A method of addressing said spatial optical modulator.
Patent CA-2642049-A1 (CA)
Inventor: LINTON CARL E
IPC: A62B9/00
Filed: 2007-02-08
Abstract: Methods for administering pressure changes to a user for the treatment and prevention of diseases and conditions are disclosed herein. Methods of administering Cyclic Variations in Altitude Conditioning Sessions (CVAC  Session(s)) for the treatment of hypertension, blood production, stem cell therapy, spinal cord injury, intervertebral disc therapy, inflammation, wound healing, ischemia, diabetes and associated complications, Alzheimer's disease, and cancer are disclosed herein.
Patent CA-2642706-A1 (CA)
Title: Biological load indicator and method of measuring biological load
Inventor: SEKIYAMA ATSUO
IPC: G01N33/53
Filed: 2007-02-16
Abstract: Disclosed are techniques capable of objectively and specifically evaluating various mental or physical conditions, of which evaluation was conventionally possible only by subjective symptom-dependent methods, such as stress and fatigue. Specifically disclosed are a stress or fatigue indicating agent including at least two factors selected from the group consisting of IL-1.beta., IL-1ra, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12, IL-13, IL-15, IL-17, IL-18, Eotaxin, FGF basic, G-CSF, GM-CSF, IFN-.gamma., IFN-.alpha., IP-10, MCP-1, MIP-1.alpha., MIP-1.beta., PDGF-BB, RANTES, TNF-.alpha., VEGF, CSF-2, TGF-.beta., neurotrophin 5, MCP-3, .beta.-2-microglobulin, angiotensin II, CSF-3, CXC chemokine ligand 1, CXC chemokine ligand 5 and HGF;  an agent for testing stress or fatigue including at least two molecules selected from the group consisting of molecules specifically recognizing the factors, respectively; a method of measuring stress or fatigue with the test agent; and an indicating agent for evaluating the intensity of mental conditions or disorders, including at least two factors selected from the factor group, wherein each of the factors is weighted.
Patent CA-2645051-A1 (CA)
Title: Automatic system for guiding, retaining and tightening steel wire rope in cranes
Inventor: VILCHEZ VILCHEZ MANOLI
IPC: B66D5/26
Filed: 2006-07-20
Abstract: The fastenings of steel cables for loading containers are subjected to high degrees of stress, resulting in the use of robust screw-type jaws. The systems currently installed on such cranes for fixing cables are fixed screw-type jaws. This is a much more versatile and flexible system that is based on a wedge mechanism that allows automatic and instantaneous (remotely controlled) actuation. The assembly includes the sliding clamps, actuation of said clamps, necessary additional guides and a tensioning device for adjustment of the cables. This solution makes it possible: to carry out the cable-change operation with the boom raised, thus allowing manoeuvring of the vessels and operation of nearby cranes; to reduce cable-replacement times; and to use the anchoring element (clamps) + tensioning device as a mechanism for adjusting the length of the branches. It is possible instantaneously to correct possible spreader misalignments.automatic system for guiding, retaining and adjusting cablesautomatic system for guiding, retaining and adjusting cables
Patent CA-2647268-A1 (CA)
Inventor: GERBER HANS-PETER
IPC: A61P13/00
Filed: 2007-03-26
Abstract: Provided are methods of treating kidney disorders in a subject by administering an effective amount of VEGFR agonist, e.g., a Flt1 agonist to a subject. The agonists are composed of compositions comprising VEGFR agonists, e.g., VEGF, antibodies directed to Flt1, Flt1 ligands, Flt1 small molecule activators, or Flt1 selective agents in a pharmaceutically acceptable carrier for use in activating Flt1.
Patent CA-2647298-A1 (CA)
Inventor: HAO MINCHUN
IPC: F16H7/12
Filed: 2007-03-12
Abstract: A tensioner comprising a base, a pivot arm pivotally connected to the base, a pulley journalled to the pivot arm, a first biasing member disposed between the base and the pivot arm, the first biasing member imparting a spring force to the pivot arm over a first operating range, a second biasing member disposed between the base and the pivot arm, and the second biasing member imparting a spring force to the pivot arm at a predetermined pivot arm position, the predetermined pivot arm position disposed within the operating range and beyond which predetermined pivot arm position the second biasing member supplements a spring force of the first biasing member.
Patent CA-2647488-A1 (CA)
Title: Threaded connection with variable flank angles
Inventor: WARD GARY W
IPC: F16L15/00
Filed: 2007-03-29
Abstract: A threaded connection for a conduit includes a pin member and a box member. The pin member includes a pin thread having a pin thread crest, a pin thread root, a pin load flank oriented at a pin load flank angle, and a pin stab flank oriented at a pin stab flank angle. The box member includes a box thread having a box thread crest, a box thread root, a box load flank oriented at a box load flank angle, and a box stab flank oriented at a box stab flank angle. At least one of the pin load flank angle, the pin stab flank angle, the box load flank angle, and the box stab flank angle varies over at least part of the threaded connection.
Patent CA-2648980-A1 (CA)
Title: Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases
Inventor: CARMON LIOR
IPC: A61K31/7105
Filed: 2007-03-29
Abstract: The present invention relates to novel uses of antisense oligonucleotides targeted to the coding region of acetylcholinesterase (AChE) for treating inflammatory disorders other than inflammatory disorders of the central nervous system or the peripheral nervous system innervating voluntary muscles. More particularly, the present invention relates to uses of antisense oligodexoynucleotides targeted to AChE mRNA for treating inflammatory disease of the gastrointestinal tract including inflammatory bowel disease.
Patent CA-2651268-A1 (CA)
Inventor: KYLE DONALD BRUCE
IPC: E05F15/10
Filed: 2001-04-06
Abstract: A system for raising and lowering a sectional overhead door between an open position and a closed position including, a counterbalance system adapted to be connected to the door, an operator motor assembly mounted proximate to the sectional overhead door in the closed position of the sectional overhead door, at least a portion of the operator motor assembly movable between a door operating position and a door locking position, and a locking assembly (370) having an engaged position to hold the motor assembly in the operating position and a disengaged position to release the motor assembly allowing it to move to the door locking position. The system may be provided with a remote light assembly having a switchable light source in sensing communication with the operator motor such that operation of the motor activates the light source. The system is further provided with a handle assembly (515) operatively engaging the motor assembly (40) and counterbalance system (30) to selectively disconnect the motor assembly (40) from the counterbalance system (30), whereby urging of a rotatable handle (516) to a disconnect position (516') allows the door (D) to be manually freely moveable with the aid of the counterbalance system (30).
Patent CA-2651860-A1 (CA)
Title: System and method for distributing a media product by providing access to an edit decision list
Inventor: TAM CHUNG MING
IPC: G06Q30/06
Filed: 2007-05-14
Abstract: The present invention provides a system and method for distributing a media product by providing access to an edit decision list. According to an embodiment of the present invention, there is provided a system for providing a consumer access to a final product comprising one or more content elements, the system comprising: an edit decision list corresponding to the final product, said edit decision list comprising statements and instructions for generating the final product from said one or more content elements; a selection means for allowing the consumer to select the edit decision list from a first source location; a computing device accessible to the consumer and having access to said one or more content elements from one or more second source locations distinct from said first source location; and a communication medium for providing said computing device access to said edit decision list; wherein said computing device is configured to access said edit decision list and implement said statements and instructions thereof to generate the final product for consumption by the consumer.
Patent CA-2652720-A1 (CA)
Title: Method and apparatus for inducing artificial hibernation of marine animal
Inventor: KIM WAN SOO
IPC: A01K67/00
Filed: 2007-03-06
Abstract: A method and an apparatus for inducing artificial hibernation of marine animal, wherein the temperature of sea water with marine animals is gradually lowered in stepwise process, while the sea water temperature is kept as is for a predetermined period of time at each step of lowering temperature, whereby the predetermined period of time maintained for each step of the lowered temperature is gradually increased to a point where changes of oxygen consumption by the marine animals greatly decreased or the changes of oxygen consumption is reached almost zero, and starting from this point, the time of constantly maintaining the sea water temperature at each step is gradually reduced to thereby ensuring a long survival rate (viability) of marine animals.
Patent CA-2655742-A1 (CA)
Title: Integral pipe and fitting assembly of polymer material and method of making same
Inventor: MEZZALIRA RINALDO
IPC: F16L33/04
Filed: 2007-04-18
Abstract: A hose and fitting assembly comprising a hose of a first thermoplastic polymer material having an end portion (9) with an inner surface (8) and an outer surface (15) and a fitting (3) of a second polymer material for connection with an external point of use. The fitting (3) has a central tubular projection (4) with an axial fluid passageway (6). The central tubular projection (4) has an inner wall (5) which defines the fluid passageway (6) and an outer wall (7), at least partly integrally coupled to the inner surface (8) of the end portion (9) of the hose (2). The hose and fitting assembly comprises reinforcement means (11 ) of a third polymer material at the periphery of the end portion (9) of the hose (2) for restraining radial deformations of the hose and providing the assembly with a good mechanical and/or hydraulic sealing capability. A method of making such assembly.
Patent CA-2657033-A1 (CA)
Title: A method of predicting breakage properties of a particulate material when subjected to impact
Inventor: KOJOVIC TONI
IPC: B02C1/00
Filed: 2007-07-10
Abstract: A method of predicting breakage properties of a particulate material when subjected to impact, the method including: calculating a breakage index for the particulate material using the following equation: Breakage Index = M{I - exp[- ~mat x k - E]} where: M represents the maximum breakage of particles for the particulate material; ~mat is a material parameter that is a function of the particulate material being broken and particle size; x is the initial particle size of the particulate material prior to impact; .EPSILON. is a measure of the specific energy applied to the particulate material; and k is the number of impacts with specific energy .EPSILON..
Patent CA-2659028-A1 (CA)
Inventor: KHASELEV OSCAR
IPC: C09D7/62
Filed: 2007-08-03
Abstract: Particles and particle films are provided. In certain examples, particles produced from a single phase process may be used to provide industrial scale synthesis of particles for use in devices such as printed wiring boards. The particles, in particular silver particles are produced by a process comprising: mixing a metal or a metal salt with a capping agent in a single phase solution; and adding a reducing agent to the single phase solution to produce capped nanoparticles.
Patent CA-2660431-A1 (CA)
Inventor: GREER JOHN JAMES
IPC: A61K31/454
Filed: 2007-08-30
Abstract: The invention is directed to a method for alleviating respiratory depress ion in a subject as a result of disease of pharmacological agents such as op iates, opioids or barbiturates. The invention also discloses pharmaceutical compositions for use with the method, the composition containing in combinat ion, an analgesic, anaesthetic, or a sedative and a positive allosteric AMPA receptor modulator in an amount sufficient to reduce or inhibit respiratory depression caused by the analgesic, anaesthetic, or sedative.
Patent CA-2664351-A1 (CA)
Inventor: KIM HAN-JOON
IPC: A61C8/00
Filed: 2007-08-15
Abstract: A high-precision implantation guide for safely and properly performing implantation treatment has been desired. In an implantation guide making method, (1) a guide block including a wearing portion and a machining portion is prepared, (2) CT image data on a patient wearing the guide block is collected, (3) the implantation position and implantation direction of the implant are determined by diagnosis according to the CT image data, and the information on the determined implantation position and implantation direction is converted into coordinate information in a machining reference coordinate system, and (4) the guide block reflecting the converted coordinate information is cut by CAD/CAM.